Information Library

Results for: Central Nervous System - Phase II/III

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • A Focus on CNS

    Brochure — July 1, 2011
    Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process.

  • Clinical – Smarter Trials, Accelerated Outcomes

    Brochure — February 16, 2011
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Exclusive Report From Scientific American

    Hear from the Experts — November 9, 2010
    In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today.

  • Advancing Clinical Research in Alzheimer's Disease

    White Paper — October 18, 2010
    This report from Quintiles’ own Alzheimer’s experts gives you an inside look at the news from ICAD 2010.

  • The Evolving Role of Neuroimaging in Future AD Clinical Trials

    Presentation — September 21, 2010
    Download the slides from Philip Scheltens, MD VU Medical Center, Amsterdam recent presentation, The Evolving Role of Neuroimaging in Future AD Clinical Trials

  • Behavior as an Outcome in Disease Modifying AD Trials

    Video — August 6, 2010
    Watch the video of Jeffrey Cummings, M.D. of Cleveland Clinic recent presentation, Behaviors as an Outcome in Disease Modifying AD Trials from the Quintiles Symposium at ICAD 2010

  • Eric Siemers, MD

    Hear from the Experts — May 20, 2010
    Eric Siemers, MD Medical Director, Alzheimer’s Disease Eli Lilly Eric Siemers, M.D. is Medical Director of the Alzheimer’s Disease Team at Eli Lilly

  • Anticipating the Challenge

    Case Study — March 3, 2010
    Extensive experience and expertise in Alzheimer's Disease accelerated outcomes in multi-country Phase II study.

  • Advancing Innovation

    Case Study — March 3, 2010
    Prescreening and safety measures simplified a Phase II study of a four-dose vaccine that required multiple rating scales.

  • Alzheimer's Inroads

    Case Study — March 3, 2010
    A global, multi-site Phase III trial required a large number of patients with a specific number of sites and patients at each site.

Page 1 of 2 (12 results)

Subscribe to Email Based on Your Interests

Set preferences